溴敌隆(Bromadilone)是1977年法国丽华制药厂发展起来的第二代抗疑血剂,1978年在加拿大和美国从商品名马其(Maki)登记推广。经国外试验认为溴敌隆与大隆、鼠得克一样,不仅具有高效安全、靶谱广、适口性好等优点,而且对第一代抗疑 Bromadilone is the second generation anti-dysenter developed in 1977 at Lihua Pharmaceutical Factory in France and was registered in 1978 in Canada and the United States under the trade name Maki. The foreign trials that bromadiolone and Dalong, rat Dake, not only has the advantages of efficient and safe, wide target range, palatability and good, but also the first generation of anti-skepticism